Does ELOTUZUMAB Cause Thrombocytopenia? 107 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 107 reports of Thrombocytopenia have been filed in association with ELOTUZUMAB (EMPLICITI). This represents 3.1% of all adverse event reports for ELOTUZUMAB.
107
Reports of Thrombocytopenia with ELOTUZUMAB
3.1%
of all ELOTUZUMAB reports
17
Deaths
51
Hospitalizations
How Dangerous Is Thrombocytopenia From ELOTUZUMAB?
Of the 107 reports, 17 (15.9%) resulted in death, 51 (47.7%) required hospitalization, and 11 (10.3%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for ELOTUZUMAB.
What Other Side Effects Does ELOTUZUMAB Cause?
Plasma cell myeloma (339)
Death (234)
Malignant neoplasm progression (227)
Pneumonia (209)
Pyrexia (183)
Drug ineffective (137)
Neutropenia (133)
Anaemia (119)
Diarrhoea (105)
Fatigue (95)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which ELOTUZUMAB Alternatives Have Lower Thrombocytopenia Risk?
ELOTUZUMAB vs ELOXATIN
ELOTUZUMAB vs ELRANATAMAB
ELOTUZUMAB vs ELRANATAMAB-BCMM
ELOTUZUMAB vs ELTROMBOPAG
ELOTUZUMAB vs ELTROMBOPAG OLAMINE